Treatment

Addressing HCV Reinfection in People Who Inject Drugs: A Comprehensive Approach to Elimination

Hepatitis C virus (HCV) remains a significant global issue, especially among people who inject drugs (PWID), who are at high risk for both prevalent and…

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women's Hospital & Teaching Hospital of Harvard Medical School

Patient Management Guidelines

Articles

END C Study Highlights Success of Decentralized HCV Treatment for Homeless Population

Researchers of the END C study evaluated the effectiveness of a decentralized, integrated model for hepatitis C virus (HCV) treatment...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

HCV Guidelines Emphasize Universal Screening, Simplified Treatment, and Global Access

Hepatitis C virus (HCV) remains a global health challenge, despite direct-acting antivirals achieving cure rates over 95%. In the United...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

Advanced Liver Disease and Hepatocellular Carcinoma Linked to Higher Mortality With Hepatitis C

Failure to achieve sustained virological response (SVR) and the presence of advanced liver disease are linked to higher mortality in...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Patients With Hemodialysis: Calls for Better Prevention

A study aimed to determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates

Decades ago, in the 1970s, cases of transfusion-associated hepatitis, called non-A, non-B hepatitis (NANBH), were often chronic, but the cause...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

Company
Contact

Partner with Us
Ambassador Program

Treatment

Addressing HCV Reinfection in People Who Inject Drugs: A Comprehensive Approach to Elimination

Jennifer Geremia,

Patient Management Guidelines

Articles

END C Study Highlights Success of Decentralized HCV Treatment for Homeless Population

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

HCV Guidelines Emphasize Universal Screening, Simplified Treatment, and Global Access

Advanced Liver Disease and Hepatocellular Carcinoma Linked to Higher Mortality With Hepatitis C

Patients With Hemodialysis: Calls for Better Prevention

Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates

© 2025 Point of Care Network, LLC. All Rights Reserved.

© 2025 Point of Care Network, LLC. All Rights Reserved.

Share